Zhejiang Chengyi Pharmaceutical Co. Ltd. Class ASSE: 603811

"Zhejiang Cheng Yi Pharmaceutical Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing

Sep 11, 2026 · Issued by Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Convening the 2026 Semi-annual Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A

"Zhejiang Cheng Yi Pharmaceutical Co., Ltd."Announcement on Resolutions of the 6th Meeting of the 5th Board of DirectorsAug 27
"Zhejiang Cheng Yi Pharmaceutical Co., Ltd."Announcement on Shareholding Reduction Plan for Directors and Senior Management MembersJul 1
Announcement on Progress in Providing Guarantee for SubsidiaryJun 23
Announcement on Implementation of Dividend Distribution for 2025Jun 19

All Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A news releases